ResMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.

CEO

Michael J. Farrell

CEOMichael J. Farrell

Employees

10,600

Employees10,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

10,600

Employees10,600

RMD Key Statistics

Market cap

30.12B

Market cap30.12B

Price-Earnings ratio

19.68

Price-Earnings ratio19.68

Dividend yield

1.14%

Dividend yield1.14%

Average volume

1.31M

Average volume1.31M

High today

$208.92

High today$208.92

Low today

$202.40

Low today$202.40

Open price

$203.33

Open price$203.33

Volume

1.18M

Volume1.18M

52 Week high

$293.81

52 Week high$293.81

52 Week low

$198.61

52 Week low$198.61

Stock Snapshot

The current ResMed(RMD) stock price is $207.78, with a market capitalization of 30.12B. The stock trades at a price-to-earnings (P/E) ratio of 19.68 and offers a dividend yield of 1.1%.

As of 2026-05-19, ResMed(RMD) stock has fluctuated between $202.40 and $208.92. The current price stands at $207.78, placing the stock +2.7% above today's low and -0.5% off the high.

ResMed(RMD) shares are trading with a volume of 1.18M, against a daily average of 1.31M.

During the past year, ResMed(RMD) stock moved between $198.61 at its lowest and $293.81 at its peak.

RMD News

TipRanks 6h

ResMed Targets Circadian Data With New Wearable Trial: What Investors Should Watch

Resmed Inc (RMD) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 10h

ResMed, Oura partner to expand access to sleep health education

Resmed (RMD) and Oura announced they are partnering to expand access to sleep health education and pathways to care. By connecting consumer-generated wellness i...

TipRanks 5d

Analyst Maintains Hold on ResMed as Noctrix Acquisition Offers Limited Incremental Growth Amid Competitive Risks

Needham analyst Michael Matson has maintained their neutral stance on RMD stock, giving a Hold rating on May 6. Claim 55% Off TipRanks Unlock hedge fund-level d...

Analyst ratings

68%

of 28 ratings

Buy

67.9%

Hold

25%

Sell

7.1%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Flowserve

Cognex

WisdomTree Japan Hedged E…

SPDR EURO STOXX 50 ETF

Cadence Design Systems

Baker Hughes Company

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.